Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
Public ClinicalTrials.gov record NCT05260359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation Bemotrizinol in Human Repeated Insult Patch Test (HRIPT) and Cumulative Irritation Test
Study identification
- NCT ID
- NCT05260359
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- dsm-firmenich Switzerland AG
- Industry
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Interventions
- 6% Bemotrizinol (BEMT) in a basic sunscreen oil formulation Drug
- 6% Bemotrizinol (BEMT) dispersion in petrolatum Drug
- Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMT Other
- Petrolatum vehicle Other
- 0.9% Saline Other
- Sodium Lauryl Sulfate 0.1% (SLS) Other
- Undosed patch Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2022
- Primary completion
- Apr 7, 2022
- Completion
- Apr 7, 2022
- Last update posted
- Aug 25, 2022
2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Eurofins | CRL, Inc. | Piscataway | New Jersey | 08854 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05260359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2022 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05260359 live on ClinicalTrials.gov.